CVE-2017-6752

Description

A vulnerability in the web interface of the Cisco Adaptive Security Appliance (ASA) 9.3(3) and 9.6(2) could allow an unauthenticated, remote attacker to determine valid usernames. The attacker could use this information to conduct additional reconnaissance attacks. The vulnerability is due to the interaction between Lightweight Directory Access Protocol (LDAP) and SSL Connection Profile when they are configured together. An attacker could exploit the vulnerability by performing a username enumeration attack to the IP address of the device. An exploit could allow the attacker to determine valid usernames. Cisco Bug IDs: CSCvd47888.

Category

7.5
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.86% Top 30%
Vendor Advisory cisco.com Vendor Advisory cisco.com
Affected: n/a Cisco Adaptive Security Appliance
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2017-6752?
CVE-2017-6752 has been scored as a high severity vulnerability.
How to fix CVE-2017-6752?
To fix CVE-2017-6752, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-6752 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-6752 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-6752?
CVE-2017-6752 affects n/a Cisco Adaptive Security Appliance.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.